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Abstract
Background: Although chromosomal instability (CIN) has been detected in many kinds of human malignancies by 
means of various methods, there is no practical assessment for small clinical specimens. In this study, we evaluated CIN 
in fine-needle aspiration (FNA) biopsied oral squamous cell carcinomas (SCCs) using fluorescence in situ hybridization 
(FISH) analysis, and investigated its prognostic significance.
Methods: To evaluate CIN status of tumors, FISH with genomic probes for the centromeres of chromosomes 7, 9, and 
11 was performed on specimens obtained by FNA from 77 patients with primary oral SCCs.
Results: High-grade CIN (CIN3) was observed in 11.7% (9/77) of patients with oral SCCs and was associated 
significantly with reduced disease-free survival (p = .008) and overall survival (p = .003). Multivariate Cox proportional 
hazards analysis showed that CIN status was significantly correlated with disease-free survival (p = .035) and overall 
survival (p = .041).
Conclusion: Analysis of CIN status using FISH on FNA biopsy specimens may be useful in predicting of recurrence and 
poor prognosis in patients with oral SCCs.
Background
Head and neck squamous cell carcinoma (HNSCC) is a
common malignancy, accounting for an estimated
274,289 new cases and 127,459 deaths worldwide in 2002,
or roughly 2.5% of all new cases of cancer and 1.9% of all
cancer deaths annually [1]. Over 50% of HNSCCs arise in
the oral cavity. Although advances in surgical techniques,
radiotherapy and chemotherapy have improved the
extent of organ preservation and overall quality of life, as
well as reducing morbidity, disease-free survival rates
(DFS) and overall survival rates (OS) for patients with
HNSCC have remained largely unchanged over the past
20 years [2]. To improve the long-term survival rate of
patients with HNSCC, it is important to find more accu-
rate prognostic markers to aid the selection of more
appropriate treatment.
It is now widely accepted that nearly all solid tumors
are genetically unstable. Genetic instability has been
shown to comprise two forms: microsatellite instability
(MIN) and chromosomal instability (CIN). MIN, which is
known to be a genetic phenotype of non-polyposis col-
orectal cancer, is observed at the nucleotide level [3]. In
HNSCC, the reported frequencies of MIN vary from 1.23
[4,5] to 57.9% [6]; in general the incidence is relatively
low. In contrast, in most solid tumors including oral
SCCs, CIN occurs at the chromosomal level, with fre-
quent gains and losses of whole chromosomes or chro-
mosomal segments. CIN has been assessed by various
methods, including flow cytometry, karyotyping, com-
parative genomic hybridization (CGH), allelotyping,
Inter-(simple sequence repeat) PCR, and genomic finger-
printing [7-12]. Although these methods are very infor-
mative, they are cumbersome for determining CIN, and
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therefore not practical for the assessment of clinical spec-
imens. On the other hand, fluorescence in situ hybridiza-
t i o n  ( F I S H )  h a s  m a d e  i t  p o s s i b l e  t o  d e t e c t  n u m e r i c a l
changes in chromosomes and genes easily and rapidly in
small surgical samples, such as those obtained by fine-
needle aspiration (FNA) biopsy. Therefore, FISH analysis
is one of the most practical methods for evaluation of
CIN in surgical specimens.
With regard to HNSCC and its subset, oral SCC, it is
well known that the occurrence of the MIN phenotype is
relatively low, and this is supported by the fact that many
loss of heterozygosity (LOH) events seem to have been
more common than MIN in HNSCC [4]. On the other
hand, many previous studies have demonstrated that
karyotypes of HNSCC and oral SCC consist of near-trip-
loid chromosome numbers and contain various patterns
of cytogenetic abnormality, including structural and
numerical aberrations [12-14]. Moreover, these features
have been confirmed by other molecular genetic tech-
n i q u e s  s u c h  a s  C G H ,  L O H ,  a n d  F I S H .  T h e s e  f i n d i n g s
indicate that CIN rather than MIN is the dominant
genetic event in carcinogenesis of oral SCCs and may play
an important role in oral cancer progression.
In the present study, we examined CIN grade using
FISH in FNA biopsy samples from primary oral SCCs,
and analyzed the association between CIN status and
clinical and histopathological factors. To our knowledge,
the present study represents the first analysis of CIN
grade in FNA biopsied oral SCC detected by FISH, and
also the first to examine whether CIN status has any
impact on clinical outcome.
Methods
Patients
Tissue samples were obtained from 77 patients (52 males,
25 females) with oral SCC who had undergone primary
surgical excision with curative intent at the Maxillofacial
Surgery, Graduate School, Tokyo Medical and Dental
University (Tokyo, Japan), between April 2000 and Octo-
ber 2006. No patients received preoperative or postoper-
ative treatment. Informed consent was obtained from all
the patients in accordance with our Institutional Review
Board guidelines. The mean age of the patients was 59.9
years (range, 20-89 years). The oral SCC samples were
derived from the tongue (n = 42), lower gingiva (n = 22),
upper gingiva (n = 4), buccal mucosa (n = 3), and the floor
of the mouth (n = 6). The clinical staging was defined on
the basis of the International Union Against Cancer TNM
classification [15]: 20 patients were stage I [T1N0M0], 30
were stage II [T2N0M0], 12 were stage III [T3N0M0, T1-
3N1M0], and 15 were stage IV [T4N0M0, anyTN2,3M0,
anyTanyNM1]. The median follow-up period was 45.4
months (range, 6.1-105 months). Tumors were classified
histopathologically as well, moderately, or poorly differ-
entiated according to their cellular differentiation as
defined by the World Health Organization criteria [16].
Disease-free survival (DFS) was calculated from the time
of initial examination to the time of local, regional, or dis-
tant recurrence of the disease, or at the five-year follow-
up. Overall survival (OS) was calculated from the time of
initial examination to the time of death, or to the time of
the five-year follow-up.
FNA biopsy samples and FISH
Sampling of the tumor cells and slide preparation for
FISH analysis were performed as described previously
[17,18]. A suspension of single cells was obtained by aspi-
rating the tumor with a 21-gauge needle. The cells were
soaked in 0.05 M KCl solution for 2 min to disrupt the
cell membranes and expose the naked nuclei, and then
fixed by addition of an equal volume of methanol/acetic
acid (3:1) solution (Carnoy). After centrifugation at 3000
rpm for 10 min, the upper layer was exchanged for Car-
noy solution. Centrifugation and solution exchange were
repeated twice, and the resulting upper layer was trans-
ferred dropwise to glass slides under steam. The speci-
mens were then air-dried and stored at -20°C until use.
To detect changes in the copy number of chromosomes
7, 9 and 11 in the oral SCC cells, we used three types of
single-color BAC clone probes specific for the centro-
meric DNA of these chromosomes. A single-color probe
specific for chromosome 7 centromeric DNA was labeled
with Spectrum Green (D7Z1 for CEP7, Vysis Inc., Down-
ers Grove; IL), one for chromosome 9 centromeric DNA
was labeled with Spectrum Orange (CEP9, Vysis Inc.),
and one for chromosome 11 centromeric DNA was
labeled with Spectrum Green (D11Z1 for CEP11, Vysis
Inc.). Single-color FISH was carried out as follows.
Briefly, the materials on the slides were aged in 2 × saline-
sodium citrate (SSC)/0.1% (v/v) NP-40 at 37°C for 30 min
and dehydrated through an ethanol series. The slides
were denatured in 70% (v/v) formamide/2 × SSC at 75°C
for 5 min and dehydrated through an ethanol series. The
probe, denatured at 75°C for 5 min, was placed on the
denatured slides, covered with Parafilm (American
National Can, Greenwich, CT), and incubated in a humid
box at 37°C overnight. After being washed at 45°C three
times in freshly prepared 50% (v/v) formamide-2 × SSC
for 10 min, SSC for 10 min, and 2 × SSC-0.1% (v/v) NP-40
for 5 min, the slides were counterstained with 4,6-diami-
dino-2-phenylindole, dihydrochloride (DAPI; 1 μg/ml).
Fluorescence microscopy
An Olympus BX50 epifluorescence microscope equipped
with × 60 and × 100 oil-immersion objectives and a tri-
ple-pass filter for Spectrum Green/Spectrum Orange and
DAPI (Vysis Inc.) was used to count the fluorescent sig-
nals. Small, round lymphocyte-like cells, and overlappingSato et al. BMC Cancer 2010, 10:182
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and damaged nuclei were ignored, and only intact nuclei,
especially large nuclei, were evaluated. Hybridization sig-
nals were counted in 100 interphase nuclei.
CIN evaluation of FISH analysis
The modal copy number of each chromosome was deter-
mined [3]. The fraction of cells with chromosome num-
bers that differed from the mode (variant fraction: F) was
calculated for each chromosome. The average variant
fraction (F-AVG) for all three chromosomes (7, 9 and 11)
was calculated as follow: F-AVG = (F7 + F9 + F11)/3,
where F7, F9 and F11 are the variant fractions of
chromosome7, 9 and 11, respectively. The degree of CIN
was graded as follows: CIN1, the percent of cells with
average nonmodal copy numbers (F-AVG) in < 20% of the
cells; CIN2, F-AVG in  20%, < 40% of the cells; CIN3, F-
AVG in  40% of the cells [19].
Statistical analysis of FISH results
The results of single-color FISH were compared with
clinicopathological information using the chi-squared
test and two-tailed Fisher exact test. The clinicopatholog-
ical information included patient age, gender, tumor site,
clinical T stage, clinical N stage, histopathological grad-
ing, and disease stage. DFS and OS were calculated using
the Kaplan-Meier method, and statistical significance was
determined by log rank test. Multivariate disease-free
and overall survival analyses were performed using the
Cox proportional hazards model. The level of signifi-
cance was set at p < 0.05. All statistical analyses were per-
formed using SPSS 15.0J software (SPSS Inc., Chicago,
IL).
Results
Modal copy number
The copy numbers of chromosomes 7, 9, and 11 were
analyzed in 77 primary oral SCCs. The modal copy num-
ber of each chromosome ranged from two (disomy) to six
(hexasomy), and the percentage of cells that did not carry
the modal copy number was quite variable (Figure 1,
Table 1).
Correlation between CIN grade in oral SCCs and 
clinicopathological parameters
CIN grade in the patients with oral SCC was determined
by FISH with centromere repeat probes for chromosomes
7, 9, and 11. CIN1 was observed in 50 out of 77 cases
(64.9%), CIN2 in 18 out of 77 cases (23.4%), and CIN3 in
9 out of 77 cases (11.7%).
The correlations between CIN grade and clinicopatho-
logical parameters in the patients with oral SCC are sum-
marized in Table 2. CIN grade was not correlated
significantly with patient age, gender, tumor site, disease
stage, clinical T stage, clinical N stage, or recurrence.
However, poorly differeciated tumor was associated sig-
nificantly with high-grade CIN (CIN3, chi-squared test, p
= .048). Moreover, CIN3 was significantly correlated with
cancer death (p = .013).
Association between CIN grade in oral SCCs and survival
Kaplan-Meier survival curves for DFS and OS are pre-
sented in Figures 2A and 2B, respectively, and clearly
demonstrate the adverse impact of high-grade CIN
(CIN3) compared with low-grade CIN (CIN1) on both
disease recurrence (log rank test, p = .008) and OS (log
rank test, p = .003). Multivariate analysis including clini-
copathological factors (age, gender, cellular differentia-
tion, and disease stage) and CIN status (CIN3 versus
CIN1 and CIN2) revealed that two factors, disease stage
and CIN status, predicted a poor outcome in DFS and OS
(Table 3).
Discussion
It has been recognized that tumors arise and progress as a
result of multiple genetic alterations, such as chromo-
somal aberrations, DNA changes (e.g., mutations, ampli-
fications, or deletions), and/or mRNA alterations through
epigenetic changes [14]. In HNSCCs including oral SCCs,
exposure to environmental agents, such as tobacco
smoke, alcoholic beverages, and viruses, including
human papillomavirus, may affect the process of carcino-
genesis [2,20]. Previous studies have demonstrated that
the karyotypes of human oral SCC cells are near-triploid
and contain numerical and structural chromosomal
abnormalities including balanced and unbalanced trans-
location, deletions, dicentric chromosomes, gene amplifi-
cation in the form of extra-chromosomal double minutes
or intra-chromosomal regions of homogeneous staining
[14]. Although these chromosomal aberrations are clonal
genetic changes, many numerical and structural varia-
tions were detected in the oral SCCs, suggesting that this
kind of cancer exhibits a high rate of CIN, and that CIN
may play an important role in their tumorigenesis. In this
study, we investigated CIN status using FISH on FNA
biopsy samples from primary oral SCCs, and analyzed the
association between CIN grade and clinical and histo-
pathological factors. Our findings clearly demonstrated
that CIN grade may be a significant predictor of recur-
rence and poor outcome in patients with this malignancy.
CIN has been observed in almost all solid tumors and
studied by various methods, including FISH. The rela-
tionship between CIN status determined by FISH and
poor prognosis has been studied in a number of human
malignancies, including lung cancer [21], malignant
astrocytic tumor [22], and lymphoma [23]. These studies
have demonstrated that CIN status can be effectively
detected using FISH analysis and is significantly associ-
ated with poor prognosis. For example, Nakamura et al.
reported that 28% of non-small cell lung cancers theySato et al. BMC Cancer 2010, 10:182
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investigated had heterogeneity of all four chromosomes
(chromosomes 3, 10, 11, and 17) examined, and were
judged to be carrying CIN [21]. Using univariate and
multivariate analysis, they also showed that CIN was
strongly associated with a worse prognosis, suggesting
that CIN can be considered an independent indicator of
poor prognosis in non-small cell lung cancer. With regard
to head and neck cancers, including oral SCC, a number
of studies have investigated numerical chromosomal
alterations by means of FISH. Hardisson et al. character-
ized numerical aberrations in routine surgical specimens
of 50 primary human SCCs of the pharynx and larynx
using FISH with DNA probes specific for the centromeric
sequences in chromosomes 8, 9, 11, and 17 [24]. They
showed that numerical abnormalities of these chromo-
somes were present in the vast majority (92%) of these
cancers. Although they clearly demonstrated an overall
positive correlation between DNA ploidy determined by
DNA flow cytometry (FCM) and numerical chromo-
somal aberration determined by FISH, they did not
examine the relationship between chromosomal status
and clinical and histopathological factors including
recurrence and survival. Soder et al. analyzed numerical
chromosomal changes during the progression of HNSCC
from low-stage non-metastasizing tumors to high-stage
metastasizing tumors and lymph node metastasis using
the FISH technique with 6 centromeric DNA probes (for
chromosomes 1, 7, 9, 11, 17, and 18) [25]. They demon-
strated a high correlation (p <.0001) between tumor met-
astatic potential and aneuploidy. Unfortunately, however,
they did not examine whether these chromosomal aber-
rations have any impact on the clinical outcome of this
cancer. Moreover, Bergshoeff et al. have reported that
CIN detection by FISH employing two centromeric DNA
probes (foe chromosomes 1 and 7) in oral SCC is strongly
associated with regional tumor outgrowth (p = .018) [26].
However, they also did not demonstrate a correlation
between numerical chromosomal changes and prognosis.
Thus, although these studies investigated numerical
chromosomal aberrations in oral SCC using FISH with
DNA probes specific for several centromeric sequences,
they did not examine the correlation between CIN, clini-
cal and histopathological factors, and outcome. In the
present study, therefore, to establish a simple and practi-
cal method for evaluation of CIN grade in primary oral
SCCs, we selected only three chromosomes 7, 9, and 11
and investigated their numerical aberrations using FISH
for interphase nuclei obtained by FNA biopsy, together
with the possible impact of CIN status on clinical out-
come.
We demonstrated that high-grade CIN was signifi-
cantly correlated with poorer outcome (OS) by univariate
(p = .003) and multivariate analysis (p = .041). Why, then,
is CIN status in oral SCC associated with a poorer prog-
nosis? There are at least two possible answers. First, in
general, CIN may induce accumulation of genetic altera-
tions. CIN gives rise to an increased rate of loss or gain of
whole chromosomes or large parts of chromosomes dur-
ing cell division. Consequently, this may result in an
imbalance of chromosome number (aneuploidy) and an
increased rate of loss of LOH [27]. These genetic altera-
tions may easily accelerate changes in the expression of
many types of cancer-related genes such as oncogenes
and tumor suppressor genes. Therefore, genetic altera-
tions of genes that may contribute to acquisition of a
malignant phenotype are more frequent in cancer cells
Table 1: The prevalence of aneusomy in surgical specimens of oral SCC
Chromosome no.
Modal copy no. 7 9 11 Total (%)
Disomy 71 72 69 212 (91.8)
Trisomy 1 3 1 5 (2.2)
Tetrasomy 5 1 7 13 (5.6)
Pentasomy 0 0 0 0 (0.0)
Hexasomy 0 1 0 1 (0.4)
Figure 1 Representative FISH analysis. Cells were hybridized with 
probes for the chromosome 7, 9, or 11 centromere (green or orange). 
(A) A representative example of a normal lymphocyte; hybridized with 
single probe for the chromosome 11 centromere (green). FISH analysis 
revealed two copies of centromeric signal in all nucleus. (B) High-grade 
CIN case. Note the presence of heterogeneous copy number of the 
centromeric signal of chromosome 9.Sato et al. BMC Cancer 2010, 10:182
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with high-grade CIN than in those without. Another pos-
sibility is that abnormalities of several significant genes
located on chromosomes 7, 9, and 11 may affect the pro-
gression of oral SCCs. Epidermal growth factor receptor
(EGFR), p16 (CDKN2A), and cyclin D1 (CCND1), which
may play an important role in the tumorigenesis and pro-
gression of this cancer, are located on chromosomes 7, 9,
and 11, respectively. Our previous studies clearly demon-
strated that numerical aberrations of these genes are a
reliable predictor of recurrence and outcome in oral
SCCs [17,18,28-30]. We have tried to compare chromo-
some number aberrations (this study) with copy numbers
of these three cancer-related genes localized on the same
chromosomes (previous studies), both performed on the
same samples. As a result, the concordance rate of chro-
mosome 7 number and EGFR gene copy number were
65-100%(average: 93%), chromosome 9 and CDKN2A
gene copy number were 17-100% (average: 81%), and
chromosome 11 and CCND1 gene copy number were 18-
100% (average: 80%). These findings have indicated that
chromosome number aberrations may significantly effect
o n  t h e  g e n e  c o p y  n u m b e r  o n  t h e  s a m e  c h r o m o s o m e .
However, only a limited number of samples, chromo-
somes, and genes were investigated in this study. More-
Table 2: Correlation between CIN status and Clinicopathological Parameters
Clinicopathological 
Parameters
CIN p valuea
Grade 1 Grade 2 Grade 3
Age (yrs)
<60 21 6 5
60 29 12 4 NS
Gender
Male 32 12 8
Female 18 6 1 NS
Tumor site
Tongue 26 11 5
Lower gingiva 15 4 3
Upper gingiva 4 0 0
Buccal mucosa 2 0 1
Floor of mouth 3 3 0 NS
Disease stage
I, II 34 12 4
III, IV 16 6 5 NS
Cellular 
differentiationb
Well to Moderate 47 15 6
Poor 3 3 3 p = .048
Clinical T stage
1, 2 40 15 5
3, 4 10 3 4 NS
Clinical N stage
04 1 1 2 5
1 to 3 9 6 4 NS
Recurrence 10 6 5 NS
Cancer death 7 6 5 p = .013
NS: not significant
a By chi-square test and two-tailed Fisher exact test
b Histopathologic diagnosisSato et al. BMC Cancer 2010, 10:182
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over, there were very large variations in the concordance
rate of each sample. For examples, with regard to chro-
mosome 11 and CCND1 gene, although the average rate
is 80%, the minimum rate is only 18%. Therefore, to clar-
ify the association between CIN and copy number aber-
rations of these cancer-related genes, further
investigations are needed.
Several mechanisms have been proposed to explain the
induction of CIN in cancer cells, including defects in
chromosomal segregation, telomere stability, cell cycle
checkpoint regulation, and repair of DNA damage [14].
Although a large number of genes responsible for CIN
have been identified in yeast, only a few such genes have
been determined in humans [31-33]. These genes include
hBUB1,  MAD2,  BRCA1,  BRCA2, and hCDC4  [34-38].
Although mutations of these genes have been reported,
such defects are rare during carcinogenesis in many kinds
of human malignancies. The present findings suggest that
the majority of these genetic defects occur as a result of
altered expression of known genes that contribute to the
development of CIN or mutation in, as yet, unidentified
genes. Recently, several studies have indicated that the
spindle protein NuMA has been shown to be critical for
spindle assembly, and plays a key role in multipolar spin-
dle formation, a frequent cause of CIN in cancer cells.
Moreover, the NUMA1 gene amplification and overex-
p r e s s i o n  h a s  b e e n  r e p o r t e d  i n  o r a l  S C C ,  s u g g e s t i n g
abnormalities of this gene may contribute to the develop-
ment of CIN in this cancer [39,40]. However, additional
examinations are required to clarify the mechanism for
CIN in cancer cells.
Conclusion
The present study has demonstrated that FISH analysis is
a sensitive, efficient, and promising method for the evalu-
ation of CIN in oral SCCs. Univariate and multivariate
analysis demonstrated that CIN grade was strongly asso-
ciated with a poor prognosis. Analysis of CIN status using
Table 3: Multivariate Cox Proportional Hazards Analysis on CIN status
Disease-free survival Overall survival
Clinicopathological 
Parameters
p value Risk ratio 95%CI p value Risk ratio 95%CI
A g e N S- -N S- -
Gender NS - - NS - -
Cellular 
differentiation
NS - - NS - -
Disease stage 0.014 3.236 1.272-8.234 0.002 5.845 1.950-17.517
CIN 0.035 3.478 1.091-11.088 0.041 3.708 1.057-13.003
CI: confidence interval
NS: not significant
Figure 2 Disease-free and Overall survival of 77 patients of oral SCCs according to CIN status. A, Kaplan-Meier curve for disease-free survival 
according to CIN status. B, Kaplan-Meier curve for overall survival according to CIN status.Sato et al. BMC Cancer 2010, 10:182
http://www.biomedcentral.com/1471-2407/10/182
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FISH on FNA biopsy specimens may be useful in predict-
ing of recurrence and poor prognosis in patients with oral
SCCs.
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